Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Oral Ketamine vs Oral Midazolam for Major Depressive Episodes
NCT07839338Phase 3Not yet recruiting
- Sponsor
- JIPMER
- Start
- Oct 2026
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in major depressive episode (MDE), sponsored by JIPMER. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
major depressive episode (MDE)
Beyond the preview
Go deeper on NCT07839338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07839338.